Littlebert,
Sadly nobody here seems interested in the Osmetech situation despite the uncanny paralels between the share dealings of the two companies.
Both have the same house broker. EVO
Both have a share shorted to death, in Osmetechs case from 13p down to 1.75p in large end of day sales.
A hefty rights issue, organised by EVO, in which 250 million new shares were created with EVO taking 60 million for themselves.
At the sametime both the ADVFN and III were infested with derampers one of who was later exposed as being an employee of Kyte Securites / Eden Group.
It stinks to high heaven and surely it would add weight to the RSV action groups case if it could be shown that the same stunt had been pulled with Osmetech.